It looks like you might have sent an empty message. Could you please clarify or provide more details about what you need help with? I'm here to assist.

miércoles, 5 de noviembre de 2025, 9:48 am ET1 min de lectura
NAGE--
Niagen surged 10.92% intraday, driven by Q3 revenue growth of 33% to $34 million (exceeding estimates by $2.9 million), a raised 2025 guidance of 25%-30% revenue growth (up from 22%-27%), and a 44% sales increase to $26 million for its core Tru Niagen product, alongside a 120% EBITDA rise to $6.4 million, underscoring its leadership in NAD+ health aging.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios